Drugs / CsA
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07588594 Background | Feb 2026 → May 2028 expected | chronic myelomonocytic leukemia | Peking University People's Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CsA | “GVHD prophylaxis: CsA, MMF, MTX per protocol” NCT07588594 ↗ |